Government would give freight capacity to medicines over food additives after no-deal Brexit
The government is to prioritise freight capacity for importing medicines and medical devices over “critical food chain dependencies” in the event of a no-deal Brexit.
According to, “category 1” goods, which are described as “critical to preservation of human or animal welfare and/or national security”, will be imported through the short straits between Dover, Folkestone, Calais, Dunkirk, and Coquelles using government-secured freight capacity.
The list of goods which are “within consideration of the government-secured freight capacity” includes prescription-only, pharmacy and general sales list medicines, as well as vaccines and biological materials, such as blood, organs, tissues and cells.
The document also includes a list of category 1 goods that “are not considered to require access to government-secured freight capacity at this stage”, including “critical food chain dependencies”.
The document describes these products as chemicals and “key additives” used in the food supply chain.
The DHSC previously said on 25 February 2019 in a written statement to parliament that 7,000 prescription-only and pharmacy medicines have been subject to government planning for a no-deal Brexit, with companies supplying the drugs asked to maintain a six-week buffer stock in the UK.
But in a letter to medicines suppliers dated 18 February 2019, the DHSC said it recognises “that not all suppliers of medical devices and clinical consumables have the capability to hold stock of their full product range in the UK” and set up a dedicated shipping channel to ferry in urgent stocks.
Citation: The Salvadore DOI: 10.1211/PJ.2019.20206275
Recommended from Pharmaceutical Press
Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.£138.50
Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.£262.50
Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.£38.00
Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.£43.00
Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.£40.00